DE69422632D1 - Antigen enthaltende nicht-ionische Tensid Vesikel - Google Patents

Antigen enthaltende nicht-ionische Tensid Vesikel

Info

Publication number
DE69422632D1
DE69422632D1 DE69422632T DE69422632T DE69422632D1 DE 69422632 D1 DE69422632 D1 DE 69422632D1 DE 69422632 T DE69422632 T DE 69422632T DE 69422632 T DE69422632 T DE 69422632T DE 69422632 D1 DE69422632 D1 DE 69422632D1
Authority
DE
Germany
Prior art keywords
ionic surfactant
containing antigen
vesicles containing
surfactant vesicles
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69422632T
Other languages
English (en)
Other versions
DE69422632T2 (de
Inventor
James Alexander
James Macdonald Brewer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Application granted granted Critical
Publication of DE69422632D1 publication Critical patent/DE69422632D1/de
Publication of DE69422632T2 publication Critical patent/DE69422632T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DE69422632T 1993-10-06 1994-10-05 Antigen enthaltende nicht-ionische Tensid Vesikel Expired - Lifetime DE69422632T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939320597A GB9320597D0 (en) 1993-10-06 1993-10-06 Improvements in and realting to vaccines
PCT/GB1994/002169 WO1995009651A1 (en) 1993-10-06 1994-10-05 Improvements in and relating to vaccines

Publications (2)

Publication Number Publication Date
DE69422632D1 true DE69422632D1 (de) 2000-02-17
DE69422632T2 DE69422632T2 (de) 2000-08-31

Family

ID=10743093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69422632T Expired - Lifetime DE69422632T2 (de) 1993-10-06 1994-10-05 Antigen enthaltende nicht-ionische Tensid Vesikel

Country Status (9)

Country Link
US (1) US5876721A (de)
EP (1) EP0722341B1 (de)
JP (1) JPH09503224A (de)
AP (1) AP9400683A0 (de)
AU (1) AU7789194A (de)
DE (1) DE69422632T2 (de)
GB (1) GB9320597D0 (de)
WO (1) WO1995009651A1 (de)
ZA (1) ZA947828B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515868D0 (en) * 1995-08-02 1995-10-04 Proteus Molecular Design Therapeutic method
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
HUP0101619A3 (en) * 1998-04-09 2003-11-28 Smithkline Beecham Biolog Adjuvant compositions
EP0976403A1 (de) * 1998-07-30 2000-02-02 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Adjuvans das ein Lungensurfactant enthält
US6787154B2 (en) * 1998-10-20 2004-09-07 Salvatore Albani Artificial antigen presenting cells
AU774442B2 (en) 1998-10-20 2004-06-24 Salvatore Albani Methods for isolation, quantification, characterization and modulation of antigen-specific T cells
US7807377B2 (en) 1998-10-20 2010-10-05 Salvatore Albani Method of isolating antigen-specific T cells employing artificial antigen presenting cells
WO2003070272A1 (en) * 2002-02-25 2003-08-28 Lyfjathroun Hf, Biopharmaceutical Research An immunological adjuvant
AU2003215884A1 (en) * 2002-02-25 2003-09-09 Lyfjathroun Hf A bioadhesive agent
DE602004019965D1 (de) 2003-11-19 2009-04-23 Survac Aps Proteine der bcl-2-familie und fragmente davon, und ihre verwendung bei krebspatienten
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
EP2422789B1 (de) 2004-05-19 2017-11-22 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Injizierbare Zusammensetzung enthaltend Natrium Deoxycholate
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
BRPI0914224A2 (pt) 2008-06-19 2019-09-24 Variation Biotechnologies Inc composições e métodos para tratar a gripe
US20110177163A1 (en) * 2008-09-18 2011-07-21 Variation Biotechnologies, Inc. Compositions and methods for treating hepatitis a
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
US20110097418A1 (en) * 2009-05-29 2011-04-28 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2767392C (en) * 2009-07-06 2017-03-14 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2840079C (en) 2010-07-06 2018-07-03 Variation Biotechnologies Inc. Compositions and methods for treating influenza
MX359103B (es) 2011-01-13 2018-09-14 Variation Biotechnologies Inc Composiciones y sus usos en el tratamiento de infecciones virales.
US20130323280A1 (en) 2011-01-13 2013-12-05 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
WO2013104995A2 (en) 2012-01-12 2013-07-18 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
WO2013111012A2 (en) * 2012-01-27 2013-08-01 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
EP3027637B1 (de) * 2013-08-01 2019-10-09 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Das glycin konjugat von beta-muricholsäure als hemmer des fxr-rezeptors zur behandlung von adipositas, insulinresistenz oder nicht alkoholischen fettlebererkrankung (nafld)
WO2017181098A2 (en) 2016-04-15 2017-10-19 Visterra, Inc. Antibody molecules to zika virus and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387A2 (fr) * 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
FR2597346B1 (fr) * 1986-04-22 1989-08-18 Oreal Procede pour faciliter la formation de niosomes en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.
US5019384A (en) * 1986-06-30 1991-05-28 Massachusetts Institute Of Technology Immunonodulating compositions and their use
LU87449A1 (fr) * 1989-02-09 1990-09-19 Oreal Procede de fabrication de mousses utilisables dans les domaines cosmetique et pharmaceutique et mousses obtenues par ce procede
IT1238343B (it) * 1989-10-16 1993-07-13 Cesalpino Andrea Fond Procedimento per la preparazione di vaccini capaci di generare non solo la risposta immune dei linfociti t helper,ma anche un'efficace risposta di linfociti t citotossici,e vaccini con queste caratteristiche
DE69101474T2 (de) * 1990-07-11 1994-07-21 Quest Int Stabilisiertes Emulsionssystem.
AU654858B2 (en) * 1991-03-28 1994-11-24 Novavax, Inc. Lipid vesicle containing water-in-oil emulsions
GB9207731D0 (en) * 1992-04-07 1992-05-27 Proteus Molecular Design Improvements in or relating to vaccines
ZA933359B (en) * 1992-05-15 1993-12-08 Sankyo Co Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
US5716611A (en) * 1996-01-02 1998-02-10 Euro-Celtique, S.A. Emollient antimicrobial formulations containing povidone iodine

Also Published As

Publication number Publication date
EP0722341B1 (de) 2000-01-12
GB9320597D0 (en) 1993-11-24
DE69422632T2 (de) 2000-08-31
ZA947828B (en) 1995-05-18
US5876721A (en) 1999-03-02
JPH09503224A (ja) 1997-03-31
AU7789194A (en) 1995-05-01
AP9400683A0 (en) 1996-04-05
WO1995009651A1 (en) 1995-04-13
EP0722341A1 (de) 1996-07-24

Similar Documents

Publication Publication Date Title
DE69422632D1 (de) Antigen enthaltende nicht-ionische Tensid Vesikel
DE69404601D1 (de) Resonantes Tunneln in Silizium
DK145493D0 (da) Antistof
DE59310313D1 (de) Detergensgemische
TR199501510A2 (tr) Sürfaktanlar.
FI930997A (fi) Platt nyckel
DE69427730D1 (de) Kristallresonator
NO941296D0 (no) Flytende rengjöringspreparat
DE59608351D1 (de) Tensidgemische
DE59302838D1 (de) Schäumende detergensgemische
DE69618940D1 (de) Tensidzusammensetzungen
DE59402088D1 (de) Ultramilde tensidmischungen
DE59409417D1 (de) Oszillator
DE69530728D1 (de) Tensidzusammensetzungen
DK0777622T3 (da) Transportindretning
DE69423197T2 (de) Überlagerungsoszillator
DE59401867D1 (de) Ultramilde tensidmischungen
DK108393D0 (da) Beholder og byggeklods
DE59406053D1 (de) Nichtionische detergensgemische
ATE221039T1 (de) Nichtionische tensidmischungen
KR940021307U (ko) 릴레이의 구조
DE59306386D1 (de) Optischer Duplexer
KR950700785A (ko) 계면활성제(surfactant)
DE59507396D1 (de) Wasserfreie tensidgemische
KR940020239U (ko) 발포기

Legal Events

Date Code Title Description
8364 No opposition during term of opposition